Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors

Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1., Science, 324, 930, 10.1126/science.1170116 Ito, 2010, Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification., Nature, 466, 1129, 10.1038/nature09303 Ficz, 2011, Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation., Nature, 473, 398, 10.1038/nature10008 Tefferi, 2009, Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML., Leukemia, 23, 1343, 10.1038/leu.2009.59 Langemeijer, 2009, Acquired mutations in TET2 are common in myelodysplastic syndromes., Nat Genet, 41, 838, 10.1038/ng.391 Jankowska, 2009, Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms., Blood, 113, 6403, 10.1182/blood-2009-02-205690 Delhommeau, 2009, Mutation in TET2 in myeloid cancers., N Engl J Med, 360, 2289, 10.1056/NEJMoa0810069 Abdel-Wahab, 2009, Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies., Blood, 114, 144, 10.1182/blood-2009-03-210039 Figueroa, 2010, Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation., Cancer Cell, 18, 553, 10.1016/j.ccr.2010.11.015 Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2., Nature, 468, 839, 10.1038/nature09586 Dupont, 2007, The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera., Blood, 110, 1013, 10.1182/blood-2006-10-054940 Marie-Desvergne, 2010, Evaluation of DNA adducts, DNA and RNA oxidative lesions, and 3-hydroxybenzo(a)pyrene as biomarkers of DNA damage in lung following intravenous injection of the parent compound in rats., Chem Res Toxicol, 23, 1207, 10.1021/tx100081p Song, 2005, Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry., Anal Chem, 77, 504, 10.1021/ac0489420 Gilles, 2009, MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9., Blood, 114, 4221, 10.1182/blood-2009-03-209932 Delhommeau, 2007, Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis., Blood, 109, 71, 10.1182/blood-2006-03-007146 Kosmider, 2009, TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia., Haematologica, 94, 1676, 10.3324/haematol.2009.011205 Kohlmann, 2010, Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1., J Clin Oncol, 28, 3858, 10.1200/JCO.2009.27.1361 Schaub, 2010, Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms., Blood, 115, 2003, 10.1182/blood-2009-09-245381 Flach, 2010, Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis., Haematologica, 95, 518, 10.3324/haematol.2009.013631 Mullighan, 2009, TET2 mutations in myelodysplasia and myeloid malignancies., Nat Genet, 41, 766, 10.1038/ng0709-766 Trowbridge, 2009, DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells., Cell Stem Cell, 5, 442, 10.1016/j.stem.2009.08.016 Bröske, 2009, DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction., Nat Genet, 41, 1207, 10.1038/ng.463 Ley, 2010, DNMT3A mutations in acute myeloid leukemia., N Engl J Med, 363, 2424, 10.1056/NEJMoa1005143